Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. We envision a world where all women and their babies have access to safe and effective therapies for treating life threatening complications of pregnancy, and those solutions must be evidence-based and affordable.
Pretzel Therapeutics is a biotechnology company focused on developing therapies for mitochondrial dysfunction. Founded by leading experts in mitochondrial biology, the company aims to create innovative treatments that address the underlying causes of mitochondrial issues. By leveraging a comprehensive understanding of mitochondrial mechanisms, Pretzel Therapeutics seeks to reverse dysfunction at its roots, potentially providing effective solutions for patients suffering from a range of conditions, including those related to aging. The company's name reflects its scientific focus on the mitochondrion, which is characterized by its unique and highly folded inner membrane, distinguishing it from other organelles in the body.
Omni is the only BI platform that combines the consistency of a shared data model with the freedom of SQL. Omni was founded in 2022 and was headquartered in California, United States.
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.
Xilis, Inc. is an oncology and precision health company that focuses on improving cancer diagnosis and treatment. Founded in 2019 and based in Chapel Hill, North Carolina, Xilis utilizes advanced organoid technologies, specifically micro-organoids, to create thousands of 3D replicas of a patient's tumor within six days. This innovative approach allows for rapid diagnostics and personalized drug screening, enabling healthcare providers to identify the most effective treatments for individual patients. The company's platform supports scalable, patient-derived models that facilitate high-throughput drug discovery, ultimately assisting physicians and pharmaceutical companies in developing tailored therapies at a reduced cost.
Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.
FYTO provides innovative solutions which improve the economic and environmental sustainability of agriculture for farmers around the world. FYTO is developing:
NOVEL NUTRIENT-DENSE CROPS that have ultra-high yields and ultra-low resource requirements, STATE-OF-THE ART CULTIVATION AND HARVESTING SYSTEMS for exceptional quality and consistency, CLIMATE-FRIENDLY METHODOLOGIES for resiliency and long-term sustainability, and a range of GROUNDBREAKING AGRICULTURAL PRODUCTS such as animal feed and biofertilizer.
Sanas is a technology company that specializes in real-time accent translation services. Its innovative software enables users to communicate effectively by allowing them to speak in any accent of their choice without noticeable lag. By addressing language barriers and accent mismatches, Sanas enhances understanding and facilitates smoother interactions. The technology is designed to be locally installed on users' devices, giving them full control over when and how to utilize the accent-matching features. This approach not only empowers users to communicate more freely but also promotes inclusivity in conversations across diverse linguistic backgrounds.
Ahana, founded in 2020 and located in San Mateo, California, specializes in PrestoDB-based ad hoc analytics solutions. As the first company to focus on bringing these offerings to market, Ahana aims to simplify ad hoc analytics for organizations of various sizes. The company's mission includes fostering growth and supporting the Presto community, which is already in extensive use by major internet companies. Ahana operates as a fully remote organization, reflecting its commitment to flexibility and modern workplace practices.
Strella Biotechnology, Inc. designs and manufactures sensors based device that maximizes the freshness of fresh produce throughout the supply chain. The company provides an ethylene-detection device that determines ripeness by calculating the ethylene gas produced by fruit and maximizes freshness and reduces spoilage of fruit. Strella Biotechnology, Inc. was founded in 2018 and is based in Philadelphia, Pennsylvania.
OMeat is a producer of cultivated meat products designed to address the environmental, health, and animal welfare issues associated with traditional animal agriculture. By growing real meat from cells outside of animals, OMeat provides a sustainable alternative that maintains the taste and nutritional value of conventional meat without the need for animal sacrifice. The company aims to economically scale the production of its sustainable meat offerings, making them delicious and affordable for consumers. Through this innovative approach, OMeat seeks to contribute to a more ethical and environmentally friendly food system.
We are building the next enterprise search engine fueled by NLP and open-source. Building on top of latest NLP research we leverage question answering & transfer learning to provide granular, semantic search results tailored to different domains.
Cookie.AI is a stealth-mode startup based in the Silicon Valley / Bay Area. We are building SaaS based security products in a dynamic and fast moving world of cybersecurity with ideas rooted in the era of privacy for the cloud. We are well-funded and backed by top-tier VCs and CEOs as angel investors. The founders are serial entrepreneurs who have experience in the full 0-to-1 journey with a successful exit with an acquisition. We are looking for founding engineers (summer interns also welcome!) with strong interests in security / cloud-native systems / identity / SaaS.
Waltz Health operates in the pharmaceutical supply chain, focusing on creating innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company develops consumer tools aimed at guiding decisions related to prescription care, with a particular emphasis on the needs of both payers and consumers. By utilizing AI-driven marketplaces, Waltz Health seeks to reduce costs and enhance the decision-making process for users. Their offerings provide better pricing information and resources that empower consumers while assisting payers in managing their pharmacy benefits more effectively.
Rooser connects seafood buyers and suppliers across Europe, providing them with the tools they need to trade efficiently, negotiate prices, and process deliveries. Rooser is located in Edinburgh, Scotland.
Gravity Sketch Limited is a London-based company that specializes in developing multi-platform three-dimensional (3D) creation tools and software solutions. Founded in 2014, the company offers products such as Gravity Sketch VR, which allows users to create unique geometries, 3D models, and artwork, and Gravity Sketch iOS, a design application for the iPad. The platform is designed to assist various industries, including transportation, industrial design, apparel, and footwear, by enabling users to trace ideas from conception through design and refinement in a virtual reality environment. By focusing on intuitive controls, Gravity Sketch aims to enhance collaboration among cross-functional teams, making the design process more efficient and cost-effective.
Rattle is a technology company that offers a Salesforce integration solution aimed at enhancing the efficiency of sales and customer experience teams. By allowing users to access and manage Salesforce directly through Slack, Rattle addresses common challenges related to Salesforce adoption. This integration enables sales representatives to log calls, track essential metrics, and update opportunities seamlessly, facilitating real-time visibility into customer relationship management. The platform has proven effective for industry leaders, saving sales representatives an average of 30 minutes per day in pipeline management and reducing data hygiene issues by up to 50%. Rattle's solution ultimately allows marketing professionals to focus more on customer engagement rather than internal processes.
Agolo, Inc. is a technology company that specializes in developing an artificial intelligence platform designed to create real-time summaries from unstructured data. Founded in 2012 and based in New York, Agolo employs machine learning and natural language processing to analyze vast amounts of information, enabling users to quickly grasp key points relevant to their interests. The platform enhances the efficiency of analysts by summarizing thousands of documents and identifying connections between subjects, thereby facilitating better decision-making in fields such as finance and intelligence. By streamlining the information processing workflow, Agolo allows professionals to focus on strategic actions rather than data interpretation.
Bonnet Ltd., founded in 2019 and based in London, develops a charging-as-a-service platform that simplifies access to public electric vehicle chargers. The company aims to alleviate the inconvenience faced by drivers who must register for multiple charging networks. Bonnet offers a subscription service that enables users, both individuals and businesses, to utilize any public charger through a single account. The platform not only provides access to a comprehensive network of charging points across Europe but also features real-time charger availability information and contactless payment options. This approach enhances the user experience while promoting a more visible and accessible charging infrastructure for businesses.
Overview Corporation specializes in developing advanced computer vision systems and smart cameras aimed at enhancing operational efficiency in wire and cable manufacturing. The company's technology focuses on real-time error detection and equipment monitoring, utilizing artificial intelligence to learn normal machine routines and identify deviations, crashes, and anomalies. Its inspection and monitoring systems are designed to prevent significant damage to products or machinery by catching issues such as misalignments and breakages early in the manufacturing process. Additionally, Overview Corporation's platform offers built-in analytics for remote factory tracking and provides users with live video feeds, event detection, and custom alerts, ensuring comprehensive operational visibility. Founded in 2018 and headquartered in San Francisco, California, the company serves the manufacturing sector across the United States.
Developer of an open-source platform designed to build bridges across the data analytics ecosystem. The company's platform connects data, hardware, and developers and builds multi-language across platform tools for accelerated data interchange and in-memory processing, enabling developers, data scientists, and data engineers to improve the toolchains and interoperability standards for data access, preparation, cleaning, analytics, and feature engineering.
Neo.tax is a tax preparation and filing service based in Mountain View, California, that specializes in assisting early-stage startups. The company offers a tax automation platform that employs machine learning algorithms to streamline the collection and organization of data from various sources, including emails, documents, project management tools, and financial systems. This technology generates comprehensive reports that detail all activities, expenses, and methodologies used to claim tax credits. By enhancing accuracy and simplifying the review process, Neo.tax aims to ensure that businesses are audit-ready, thereby facilitating a more efficient and reliable tax filing experience.
Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its IMPACT™ platform, Seismic Therapeutic aims to tackle key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This comprehensive approach facilitates the creation of optimized therapies that can reach patients more quickly. The company is developing a pipeline of innovative biologics targeting adaptive immune system dysregulation, with the goal of treating autoimmune diseases.
TenSixteen Bio is a biotechnology company based in San Francisco that specializes in developing innovative therapeutics for various age-related disorders. The company focuses on leveraging somatic mosaicism and clonal hematopoiesis in its approach to precision medicine, aiming to address complex diseases such as cancer and cardiovascular conditions. By utilizing advanced DNA analysis, TenSixteen Bio seeks to discover and develop new treatments that can enhance the capabilities of pharmaceutical companies in managing these diseases. Co-founded by Foresite Labs, TenSixteen Bio is dedicated to transforming the future of healthcare through its unique therapeutic strategies.
Wonder is a gaming company focused on creating an all-in-one gaming platform for Android mobile devices. The platform enables users to play, stream, and share games seamlessly across various devices, thereby enhancing the overall gaming experience. In addition to its software solutions, Wonder is also involved in developing VR-ready gaming hardware. Currently, the company operates in stealth mode, suggesting that it is in the early stages of development and may be working on innovative features or products.
Developer of weight loss application designed to recommend meals and exercises that transform the weight loss journey. The company's software along with a wearable device provides glucose monitoring and visualizes metabolism in real time, enabling users to track their glucose count and keep their diet under control.
We believe everyone should have the opportunity to live their best lives and age with dignity. That’s why we’re reinventing primary care with an approach designed to profoundly improve the healthcare and aging experience for older adults and their loved ones.
Modern Age is a health and wellness platform focused on improving the aging process for individuals. It offers health monitoring software that employs computer vision and machine learning to assess skin, hair, and bone health. The platform also integrates data collected from smart bands to create a comprehensive digital record of an individual's well-being. By analyzing this information, Modern Age provides personalized insights and treatment recommendations, empowering users to manage their health more effectively and lead healthier lives as they age.
Resistant AI protects the machine learning system from adversarial manipulation and advanced fraud. We believe that responsible and systematic adoption of machine learning techniques can profoundly improve our lives. Our mission is to accompany our customers on this way and to ensure that the risks related to machine learning and AI adoption are responsibly detected, managed and resolved.
Sprinter Health is a mobile health company that specializes in providing on-demand healthcare services directly to patients' homes. By sending full-time nurses and phlebotomists, known as "Sprinters," the company aims to improve access to preventive care and enhance the overall patient experience. Sprinter Health employs a cost-effective, hybrid care model that facilitates connections between patients and necessary healthcare services, ultimately striving to improve health outcomes and patient satisfaction. This approach allows patients to receive quality medical care in the comfort of their own homes, ensuring convenience and accessibility without compromising on care quality.
Matter is a social reading application based in the United States that focuses on articles, blogs, and newsletters. The platform aims to enhance users' reading experiences by curating and presenting high-quality content, helping them discover better material online. Through its user-friendly interface, Matter facilitates engagement with a diverse range of written works, making it easier for individuals to connect with relevant information and insights.
Developer of company management platform designed for finance and executive teams to take action and improve business outcomes. The company's platform offers automated reporting solutions, plans modeling tools, data visualization, and integration of all the aspects of company management, helping executives to automate their reporting, empower collaboration, and make their data more actionable.
Altana AI specializes in developing artificial intelligence software solutions for supply chain management, aimed at enhancing visibility and risk management in global trade. Founded in 2018 and based in New York, the company leverages extensive economic data to create a shared AI platform that facilitates better decision-making for governments, businesses, financial institutions, and logistics providers. Its flagship product, The Altana Trade Knowledge Graph, provides a real-time overview of transactions, ownership, movements, cyber activities, and associated risks within the global trade network. By integrating various data sources and utilizing machine learning, Altana AI seeks to make trade safer, more efficient, and more profitable for its clients.
Ahana, founded in 2020 and located in San Mateo, California, specializes in PrestoDB-based ad hoc analytics solutions. As the first company to focus on bringing these offerings to market, Ahana aims to simplify ad hoc analytics for organizations of various sizes. The company's mission includes fostering growth and supporting the Presto community, which is already in extensive use by major internet companies. Ahana operates as a fully remote organization, reflecting its commitment to flexibility and modern workplace practices.
Nym Health Inc. specializes in developing advanced medical coding technology aimed at enhancing revenue cycle processes within healthcare facilities. Its flagship product, Nym, offers a direct-to-billing autonomous coding solution that significantly reduces claims denials and operational costs while accelerating payment cycles and ensuring audit-readiness. The platform automatically identifies and captures relevant clinical information from patient charts, assigning codes only to fully understood cases; unhandled charts are sent back for human coding. Additionally, Nym provides a detailed audit-trail view that explains the rationale behind each coding decision, facilitating quick comprehension for validation, compliance, and appeals purposes. Founded in 2017 and headquartered in Boston, Massachusetts, the company also maintains a research and development center in Tel Aviv-Yafo, Israel.
Xilis, Inc. is an oncology and precision health company that focuses on improving cancer diagnosis and treatment. Founded in 2019 and based in Chapel Hill, North Carolina, Xilis utilizes advanced organoid technologies, specifically micro-organoids, to create thousands of 3D replicas of a patient's tumor within six days. This innovative approach allows for rapid diagnostics and personalized drug screening, enabling healthcare providers to identify the most effective treatments for individual patients. The company's platform supports scalable, patient-derived models that facilitate high-throughput drug discovery, ultimately assisting physicians and pharmaceutical companies in developing tailored therapies at a reduced cost.
Dyno Therapeutics Inc. specializes in the development of adeno-associated virus (AAV) vectors for in vivo delivery of gene therapies. Founded in 2018 and based in Cambridge, Massachusetts, the company utilizes an artificial intelligence-driven approach that integrates DNA synthesis, sequencing, and machine learning. This innovative methodology enables the design of novel gene vectors with an emphasis on cell-targeting capsid proteins derived from AAV, which is recognized as the most commonly used vector in gene therapy applications. By leveraging quantitative high-throughput in vivo experimentation, Dyno Therapeutics aims to enhance the effectiveness and precision of gene therapy solutions.
Nearby is a computer software company that helps businesses and companies to connect with nearby customers. The company helps businesses put their inventory online, and adds their store to the marketplace for their town.
Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions. The company was founded in 2021 and is headquartered in Stamford, CT.
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral families to protect humanity from known and future viruses. Its portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The Company’s energetic team of world-renown biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses.
nPlan Limited specializes in developing artificial intelligence-based software for construction project management. Founded in 2017 and headquartered in London, the company employs machine learning technology to enhance schedule reliability by analyzing past project performances. Its software identifies risks by detecting inconsistencies in task execution patterns and offers recommendations to mitigate these issues. Additionally, nPlan provides statistical insights into risk attribution for individual activities, helping project managers make informed decisions for future construction endeavors.
Blockchain.com operates a comprehensive platform that enables users to buy, hold, and utilize cryptocurrencies, aiming to create an accessible financial system for the internet. With over 50 million users, it offers a straightforward method for engaging with digital currencies, including features for trading, sending, receiving, securing, and borrowing them. The platform also includes a widely used explorer for tracking crypto market activities and an exchange that facilitates fast trading experiences. Additionally, Blockchain Ventures, supported by Blockchain.com, invests in distributed ledger technology (DLT) projects that foster societal benefits and advance the industry, promoting innovative applications of DLT beyond financial services. Overall, Blockchain.com seeks to revolutionize the financial landscape by enabling quick transactions without intermediaries and providing essential tools for real-time market insights.
SpyBiotech Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in the development of innovative vaccines through its proprietary biotechnology platform. The company utilizes a unique molecular superglue to bond antigens to viruses and other particles, facilitating the rapid creation of vaccines aimed at a variety of diseases. This advanced technology enables medical institutions and research centers to produce next-generation vaccines that demonstrate improved efficacy and reduced development time, thereby enhancing the overall vaccine development process.
Nothing is removing the barriers between people and technology to create a seamless digital future.
Redpanda is a queue for people who deal with massive data streams.
Social Media Marketing Platform.
Air Protein, based in Berkeley, California, is a startup focused on creating sustainable protein from carbon dioxide using a proprietary probiotic process. This innovative technology allows the company to develop protein-enriched food products, such as meat-free burgers, pasta, cereals, and beverages, without the use of hormones, pesticides, or herbicides. By utilizing elements from the air, Air Protein's method significantly reduces the land and water required compared to traditional meat production, providing a sustainable alternative for consumers who seek to enjoy protein-rich foods while minimizing environmental impact. The company is a venture of Kiverdi, a biotechnology firm dedicated to advancing food sustainability.
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer.
Found is dedicated to improving people’s overall wellbeing by making evidence based weight loss accessible & affordable for all.
PostHog is increasing the number of successful products in the world. We do that by providing a platform for open-source product analytics. This helps software teams understand user behaviour. We took part in Y Combinator’s W20 cohort, and had the most successful B2B software launch on HackerNews since 2012, with a product that was just 4 weeks old. Our team is a combination of former CTOs and YC founders all turned developers, alongside some of the best developers from the world's largest tech companies who have the experience to help us handle scalability. We're all remote, and we've raised enough to pay top of market. We are proudly backed by some of the best VCs and Investors in the world, such as Y Combinator. We believe in product-led growth, while we build something awesome and let our product bring the users, rather than an outbound sales team and regular cold calls. Check out posthog.com/careers if you want to be part of this journey.
Olive AI, Inc. specializes in artificial intelligence and robotic process automation solutions tailored for healthcare organizations. The company provides an AI-as-a-Service platform designed to streamline various workflows, including claim status checks, account updates, and prior authorizations. Founded in 2012 and headquartered in Columbus, Ohio, Olive aims to alleviate the burden of repetitive, high-volume tasks through automation, allowing healthcare professionals to focus on more complex responsibilities that require human creativity and empathy. Originally established as CrossChx, Inc., the company rebranded to Olive AI, Inc. in July 2018, reflecting its commitment to enhancing operational efficiency in the healthcare sector.
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.
Headway is a New York-based mental healthcare system provider that connects patients with therapists through a health insurance advisory platform. Founded in 2019 by Andrew Adams, Jake Sussman, Dan Ross, and Kevin Chan, the company aims to make mental healthcare more accessible and affordable. It operates a virtual network of therapists who accept insurance, allowing patients to schedule video or in-person sessions online. In addition to its mental health services, Headway also offers administrative support to therapists who typically do not accept insurance, thereby facilitating the expansion of their practices. By streamlining the connection between patients and providers, Headway seeks to improve the overall accessibility of mental health services.
Nym Health Inc. specializes in developing advanced medical coding technology aimed at enhancing revenue cycle processes within healthcare facilities. Its flagship product, Nym, offers a direct-to-billing autonomous coding solution that significantly reduces claims denials and operational costs while accelerating payment cycles and ensuring audit-readiness. The platform automatically identifies and captures relevant clinical information from patient charts, assigning codes only to fully understood cases; unhandled charts are sent back for human coding. Additionally, Nym provides a detailed audit-trail view that explains the rationale behind each coding decision, facilitating quick comprehension for validation, compliance, and appeals purposes. Founded in 2017 and headquartered in Boston, Massachusetts, the company also maintains a research and development center in Tel Aviv-Yafo, Israel.
Pixie Labs Inc. specializes in developing tools that enhance application management within Kubernetes environments. Founded in 2018 and based in San Francisco, the company offers a zero-touch, unsampled edge monitoring system that enables developers to instantly debug applications without altering code or manually configuring dashboards. Its platform seamlessly integrates with any Kubernetes environment through a single command, automatically collecting baseline performance data and presenting it in pre-configured live views. This functionality allows developers to efficiently explore, monitor, secure, and manage their applications, providing essential insights into production environments.
Pixie Labs is a digital product incubator located in Shoreditch, London. Within its initial six months, the company developed two applications, three prototypes, and several one-day projects known as "Friday hacks." The firm has provided consulting services to prominent brands including The Times of London and HomeServe Plc. Among its notable creations are Tagstar V8, a tool designed for managing Instagram marketing campaigns; BitFriends, which facilitates Bitcoin trading among friends; Echelon, a corporate solution for handling multiple Twitter accounts; WhisperKey, a secure browser-based messaging service; and an Energy Bill Calculator aimed at helping users monitor gas and electricity consumption to lower their monthly expenses. The founder's responsibilities encompass hiring, sales, fundraising, business management, and overseeing technical product direction.
Censys, Inc. is a cybersecurity company specializing in internet scanning and asset identification solutions. Founded in 2017 and based in Ann Arbor, Michigan, Censys provides an internet device search engine that allows users to discover and analyze devices connected to the Internet, including computers, servers, and smart devices. The platform is utilized for various applications such as attack surface management, monitoring remote workforces, and identifying potential threats. Censys is recognized for delivering real-time visibility and risk assessments, making it a valuable resource for researchers, corporations, and government entities. The company's data-driven security solutions are employed by notable organizations, including FireEye, Google, NATO, and the U.S. Department of Homeland Security, to enhance their cybersecurity measures and proactively address threats.
Invivyd is a biotechnology company focused on developing advanced antibodies to neutralize SARS-CoV-2, SARS-CoV-1, and other potentially emerging coronaviruses. Founded in 2020 and headquartered in Waltham, Massachusetts, the company aims to create best-in-class therapeutic and prophylactic treatments that surpass the efficacy of existing antibody programs. Its innovative portfolio features multiple non-competing antibodies, each targeting distinct viral epitopes, which is designed to minimize the risk of viral escape. By leveraging cutting-edge antibody discovery technologies, Invivyd seeks to enhance the potency and durability of its antibody candidates, addressing a critical need in the ongoing fight against coronaviruses.
Snorkel AI, Inc. is a technology company that specializes in developing an end-to-end machine-learning platform aimed at facilitating the creation, management, and monitoring of AI applications. Central to its offerings is Snorkel Flow, a data-first platform that enables users to programmatically label and augment training data, manage data for AI purposes, and deploy various machine learning models. The platform is particularly effective in extracting entities and structured information from complex documents, making it valuable across multiple sectors, including finance, government, telecommunications, healthcare, and e-commerce. Snorkel AI's innovative approach incorporates weak supervision technology, allowing both developers and non-developers to focus on data-related tasks efficiently. Founded in 2016 and headquartered in Palo Alto, California, Snorkel AI also contributes to the academic community by publishing peer-reviewed research on its core technologies.
Fauna, Inc. offers a cloud-based data application programming interface (API) designed for serverless applications, primarily through its product, FaunaDB. This NoSQL database combines a distributed transactional query engine with robust scalability and policy-based security features. FaunaDB provides a web-native GraphQL API that can be accessed from browsers, mobile clients, or serverless functions, while its serverless query language (FQL) enhances development by allowing complex queries that integrate various data types. The platform supports a wide array of programming languages and frameworks, including JavaScript, Python, and Ruby, facilitating seamless connections for developers. Fauna's database solutions emphasize unified capabilities across relational, temporal, and graph data, ensuring consistent performance and strong security measures. Founded in 2011 and headquartered in San Francisco, Fauna has garnered trust from notable clients like Nextdoor and NVIDIA and is supported by prominent venture capital investors.
Sana Biotechnology is a biotechnology company focused on developing engineered cells as therapies for various diseases. Incorporated in 2018 and based in Seattle, Washington, with additional offices in South San Francisco and Cambridge, the company leverages recent scientific advancements to reprogram cells or replace damaged cells and tissues. Sana's mission is to create a new class of medicines that address unmet treatment needs across a wide range of therapeutic areas, including oncology, diabetes, autoimmune disorders, and central nervous system conditions. Its pipeline includes several product candidates, such as SC291, SC262, SC255, and UP421, aimed at transforming the approach to disease treatment.
Verve Therapeutics is a biotechnology company focused on developing innovative therapies aimed at editing the adult human genome to provide lifelong protection against coronary artery disease, a leading global cause of mortality. Founded in 2018 and based in Cambridge, Massachusetts, with a research facility in Philadelphia, the company employs gene-editing technology to create treatments that shift the management of cardiovascular diseases from chronic care to potentially curative interventions. Its initial programs concentrate on the PCSK9 and ANGPTL3 genes, which are recognized for their roles in regulating blood lipids, specifically low-density lipoprotein cholesterol. Verve Therapeutics collaborates with partners such as Beam Therapeutics and Verily to enhance delivery technologies for its cardiovascular treatments.
Owkin is an artificial intelligence company founded in 2016, with headquarters in New York and an additional office in Paris. The company focuses on developing machine learning software for medical research, enabling researchers to test AI models on distributed data. Owkin's offerings include Owkin Lab, which facilitates data connectivity by therapeutic area; Owkin Loop, which provides validated and packaged models; and a comprehensive software stack for full-stack services. The company currently has 30 live models and an additional 40 in development. Owkin aims to empower medical researchers in hospitals, universities, and pharmaceutical companies to better understand variations in drug efficacy among patients, enhance the drug development process, and identify optimal treatments for individual patients, ultimately improving treatment outcomes. The company is supported by various investors and has a scientific board to guide its research initiatives.
Ventus Therapeutics U.S., Inc. is a biopharmaceutical company based in Natick, Massachusetts, with an additional location in Montreal, Canada. Founded in 2019, it focuses on discovering and developing novel small-molecule medicines that target the innate immune system to address autoimmune diseases, inflammatory diseases, and cancer. The company employs a structural immunology platform that integrates protein engineering to elucidate molecular structures and mechanisms of action. This platform facilitates the development of precise binding and functional screening assays, as well as structure-based modeling. Ventus Therapeutics is advancing an emerging pipeline of drug programs aimed at key targets within the innate immune system, leveraging its proprietary capabilities in rational and structure-based drug design.
ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, ROME Therapeutics is pioneering the exploration of the repeatome, which consists of extensive regions of genetic material previously considered "junk DNA." The company has identified several drug targets and is actively advancing multiple discovery programs. To facilitate its research, ROME has assembled a team of experts across various disciplines, including oncology, immunology, virology, and machine learning, to harness this uncharted area of biology for therapeutic advancements.
Alkira, Inc. is a network cloud company that offers an end-to-end networking platform designed for hybrid and multi-cloud environments. Founded in 2018 and based in San Jose, California, Alkira provides its services through a pay-as-you-go model, allowing customers to connect their local systems and cloud workloads to the Alkira Cloud Exchange Points. The platform enables on-demand activation of security and other services that can auto-scale based on utilization. Alkira's Network Cloud solution allows businesses to easily create and manage their network infrastructure using an intuitive digital design canvas, facilitating rapid deployment. The company serves a diverse clientele, including Fortune-100 enterprises and leading managed service providers, by delivering integrated network and security services along with operational visibility and governance.
Universe is a mobile-based website builder established in 2014 and headquartered in Brooklyn, New York. The platform aims to empower users to create customized websites quickly and easily, catering to the needs of small business owners and individuals who prefer mobile solutions. By offering a unique approach that eliminates complicated templates, Universe utilizes customizable website filters that allow users to arrange photos, videos, and icons on a grid pattern through a simple drag-and-drop interface. This enables users to build mobile-optimized websites in just minutes using the company's iOS app, providing them with full control over their online presence.
Dandelion Energy, Inc., founded in 2017 and headquartered in Palo Alto, California, specializes in affordable geothermal heating and cooling solutions for residential properties. The company's innovative home geothermal system replaces traditional air conditioning and heating equipment with a heat pump and underground pipes that efficiently transfer thermal energy between the earth and the home. This proprietary installation process allows homeowners to transition from conventional heating fuels to renewable geothermal energy, providing an environmentally friendly and cost-effective alternative for temperature regulation and hot water production.
EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before.
The company was founded in 2019 and is based in Cambridge, Massachusetts, United States.
Merlin Labs is building an autonomous infrastructure for the sky above us, enabling goods, and eventually people, to fly without pilots.
Kindbody is a health and technology company focused on providing comprehensive fertility services tailored for modern women. Their offerings include intrauterine insemination, in-vitro fertilization, egg and embryo freezing, as well as support for donors. In addition to fertility treatments, Kindbody provides a range of holistic health services, including maternity care, gynecology, and wellness support. By leveraging modern technology, Kindbody aims to improve access to affordable healthcare, ensuring that women can receive quality services that enhance their overall health and wellbeing.
Kindbody is a health and technology company focused on providing comprehensive fertility services tailored for modern women. Their offerings include intrauterine insemination, in-vitro fertilization, egg and embryo freezing, as well as support for donors. In addition to fertility treatments, Kindbody provides a range of holistic health services, including maternity care, gynecology, and wellness support. By leveraging modern technology, Kindbody aims to improve access to affordable healthcare, ensuring that women can receive quality services that enhance their overall health and wellbeing.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Kronos Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing innovative cancer therapeutics. Founded in 2017 and based in San Mateo, California, the company concentrates on targeting dysregulated transcription factors and the associated transcriptional regulatory networks that contribute to cancer progression. Its lead candidate, entospletinib, is a selective inhibitor aimed at spleen tyrosine kinase for treating acute myeloid leukemia. Additionally, Kronos Bio is advancing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9, intended for the treatment of MYC-amplified solid tumors. The company employs advanced techniques, including high-throughput small-molecule microarrays and targeted protein degradation, to discover potent compounds that can effectively modulate challenging cancer targets.
Firefly Systems Inc., founded in 2017 and based in San Francisco, California, specializes in street-level digital media through its innovative advertising platform. The company installs digital displays on rideshare vehicles and taxis, creating a unique out-of-home advertising network that leverages location-based technology and first-party data for precise audience targeting. Firefly's system enables the delivery of engaging, full-screen advertisements that are responsive to the surrounding environment, allowing brands to amplify their marketing efforts in real-time. By utilizing 4G and LTE cellular transmission, Firefly connects clients with flexible advertising solutions while providing measurable insights on campaign effectiveness and audience engagement.
Locanabio, Inc. develops RNA-targeted gene therapies to treat a spectrum of underserved diseases. It offers therapies for neuromuscular, neurodegeneration, and ophthalmology diseases. Locanabio, Inc. was formerly known as Locana, Inc. and changed its name to Locanabio, Inc. in July 2020. The company was founded in 2016 and is based in San Diego, California.
Verve Therapeutics is a biotechnology company focused on developing innovative therapies aimed at editing the adult human genome to provide lifelong protection against coronary artery disease, a leading global cause of mortality. Founded in 2018 and based in Cambridge, Massachusetts, with a research facility in Philadelphia, the company employs gene-editing technology to create treatments that shift the management of cardiovascular diseases from chronic care to potentially curative interventions. Its initial programs concentrate on the PCSK9 and ANGPTL3 genes, which are recognized for their roles in regulating blood lipids, specifically low-density lipoprotein cholesterol. Verve Therapeutics collaborates with partners such as Beam Therapeutics and Verily to enhance delivery technologies for its cardiovascular treatments.
Insitro, Inc. is a data-driven drug discovery and development company based in South San Francisco, California, founded in 2018. The company utilizes machine learning and high-throughput biology to transform the traditional processes of drug discovery and delivery. By generating extensive functional genomic datasets and aligning them with patient data through innovative machine learning techniques, Insitro builds predictive models that aim to address critical challenges in pharmaceutical research and development. These models facilitate accelerated target selection and the design of effective therapeutics, ultimately enhancing the efficiency of drug development and informing clinical strategies. The focus of Insitro's work includes the treatment of nonalcoholic steatohepatitis (NASH), showcasing its commitment to addressing significant health issues through advanced technology.
Buoyant, Inc. is a technology company based in San Francisco, California, founded in 2015 by former Twitter infrastructure engineers. The company specializes in developing open-source software, particularly through its flagship product, Linkerd, which is an open-source network proxy designed to function as a service mesh. A service mesh enables efficient management, control, and monitoring of service-to-service communication within cloud-native applications. Buoyant's offerings aim to enhance the speed, security, and reliability of applications, supporting various hosting activities such as web hosting and application service provisioning. The company is well-funded and has garnered backing from prominent investors, striving to provide robust capabilities to organizations seeking to improve their application infrastructure.
Determined AI, founded in 2017 and based in San Francisco, California, specializes in developing a deep learning management platform that streamlines the process of building and deploying machine learning models. The company's platform enhances developer productivity by facilitating distributed training and hyperparameter searches, while also automating the tracking, sharing, and reproduction of experiments and metrics. This approach allows clients to significantly reduce their time-to-market, improve resource utilization, and mitigate risks associated with model development. Through its innovative software, Determined AI aims to transform the efficiency and effectiveness of deep learning workflows.
Owkin is an artificial intelligence company founded in 2016, with headquarters in New York and an additional office in Paris. The company focuses on developing machine learning software for medical research, enabling researchers to test AI models on distributed data. Owkin's offerings include Owkin Lab, which facilitates data connectivity by therapeutic area; Owkin Loop, which provides validated and packaged models; and a comprehensive software stack for full-stack services. The company currently has 30 live models and an additional 40 in development. Owkin aims to empower medical researchers in hospitals, universities, and pharmaceutical companies to better understand variations in drug efficacy among patients, enhance the drug development process, and identify optimal treatments for individual patients, ultimately improving treatment outcomes. The company is supported by various investors and has a scientific board to guide its research initiatives.
Maze Therapeutics is a biotechnology company based in South San Francisco, California, that specializes in the development of genetic modifier therapeutics. Founded in 2017 and formerly known as Modulus Therapeutics, the company is dedicated to translating genetic insights into innovative medicines. Maze Therapeutics utilizes a comprehensive approach that integrates large-scale human genetics data, functional genomics, and various drug discovery methodologies. This approach allows the company to identify modifier genes that offer protection against diseases, enhancing the understanding of target biology and informing drug development strategies. By leveraging these insights, Maze Therapeutics aims to facilitate the creation of novel therapies that can benefit patients.
Lightmatter, Inc. is an artificial intelligence (AI) hardware company based in Boston, Massachusetts, that specializes in integrated optical technology to develop advanced computing processors. Founded in 2017, the company has created a silicon chip that utilizes light signals for processing, offering a new approach to AI computation. This technology accelerates critical operations in deep neural networks by employing programmable photonic elements alongside traditional transistors, enhancing the speed and efficiency of data processing while minimizing power consumption. Lightmatter's innovations aim to improve various AI applications, including image recognition and natural language processing, contributing to the advancement of next-generation AI-powered computing solutions.
Veo Robotics, Inc., founded in 2016 and based in Waltham, Massachusetts, specializes in developing robotics systems that enhance manufacturing processes. The company focuses on creating industrial automation products that allow high-performance robots to work collaboratively and safely alongside human workers. By integrating advanced computer vision, 3D sensing, and artificial intelligence, Veo Robotics' products aim to create more flexible, productive, and efficient manufacturing workcells. Their proprietary algorithms and distributed sensing technologies enable clients to improve productivity while reducing operating costs in both manufacturing and logistics environments.
Dandelion Energy, Inc., founded in 2017 and headquartered in Palo Alto, California, specializes in affordable geothermal heating and cooling solutions for residential properties. The company's innovative home geothermal system replaces traditional air conditioning and heating equipment with a heat pump and underground pipes that efficiently transfer thermal energy between the earth and the home. This proprietary installation process allows homeowners to transition from conventional heating fuels to renewable geothermal energy, providing an environmentally friendly and cost-effective alternative for temperature regulation and hot water production.
Dandelion's vision is to enable frictionless discovery of content and commerce. In a world where its easy for anyone to be a seller, it should be easy for anyone to be a marketer too. Dandelion provides the platform to storefronts, marketplaces, and their participants to make that happen.
Homebound Inc. is a technology-driven custom home builder based in Santa Rosa, California, founded in 2017. The company specializes in constructing residential homes and offers a comprehensive range of support services, including architecture, design, financing, and insurance consultancy. Originating in response to the 2017 Northern California wildfires, Homebound aims to simplify the homebuilding process by providing a transparent and streamlined experience for homeowners. It manages the entire building journey, assisting clients from insurance negotiation and architectural design to permitting and construction. By leveraging user-friendly technology and a network of qualified building professionals, Homebound addresses the complexities and uncertainties homeowners face, particularly in the aftermath of natural disasters, enabling them to rebuild their homes more efficiently.
Machinify, Inc. is a data-to-cash platform that leverages artificial intelligence to help enterprises enhance their core operations. Founded in March 2016 and based in Palo Alto, California, the company offers a suite of services including AI Cloud, which manages and stores real-time semi-structured and unstructured data; AI Studio, a user-friendly interface for building and testing AI models; and AI Runtime, which facilitates the creation of infrastructure for real-time predictions. By automating data collection, transformation, and product deployment, Machinify enables businesses to make informed decisions from their data, ultimately unlocking hidden profits and streamlining operations. The company serves various sectors, including healthcare, by allowing domain experts to transform raw data into actionable insights.
Kitchen United, Inc. is a company that provides food production facilities specifically designed for restaurants and food service providers. Founded in 2017 and headquartered in Pasadena, California, it offers shared commercial kitchen spaces along with business intelligence solutions to support entrepreneurial caterers, pop-ups, mobile food vendors, and start-ups. By providing a turnkey solution, Kitchen United helps restaurant brands expand their operations with minimal risk and investment. Its facilities enable these businesses to efficiently produce food for pick-up and delivery, facilitating their entry into the food delivery market. The company operates locations in major cities across the United States, including Austin, Chicago, Los Angeles, San Francisco, New York City, and Scottsdale.
Lambda Inc., operating as Lambda School, specializes in online education focused on coding and computer science in the United States. Founded in 2016 and based in San Francisco, the institution offers training in various fields, including software engineering, artificial intelligence, machine learning, and web development. Students engage in both online and live training sessions that feature hands-on projects, pair programming, and code reviews conducted by instructors. Lambda School aims to identify and cultivate untapped talent for in-demand jobs, pioneering a unique educational model where the institution invests in students' futures rather than requiring upfront tuition payments.
Yellowbrick Data, Inc. is a technology company founded in 2014 and headquartered in Palo Alto, California, with additional offices in Salt Lake City, Hong Kong, and London. The company specializes in developing and deploying data warehouse solutions, offering both on-premises and cloud-based options. Its platform is designed to efficiently store, transform, and analyze large volumes of business data, enabling organizations to run complex mixed workloads and support numerous concurrent users. Yellowbrick’s data warehouse allows for seamless analytics across various environments, including private and public clouds, while delivering superior performance and cost-effectiveness. By addressing challenges such as high availability and scalability, Yellowbrick Data empowers enterprises to make faster, data-driven decisions.
Blavity, Inc. is a media tech company founded in 2014 and based in San Francisco, California. It operates an online community that caters to multicultural creators and influencers, primarily focusing on the lives of Black millennials and Gen Z. Blavity partners with content creators to expand their reach, amplify their messages, and support their entrepreneurial endeavors. The company is known for its diverse network of platforms and brands, delivering original content, videos, and unique experiences tailored to its audience.
Viz.ai, Inc. specializes in healthcare imaging software designed to enhance stroke care through the use of artificial intelligence. The company's flagship technology synchronizes treatment by reducing delays in patient care, enabling rapid identification of large vessel occlusion (LVO) strokes using advanced deep learning algorithms. Key offerings include Viz LVO, which alerts on-call stroke teams based on CT angiogram images, and Viz CTP, which analyzes CT perfusion images and generates critical parametric data. Additionally, Viz HUB facilitates communication among clinical teams to coordinate care efficiently, while Viz VIEW allows healthcare professionals to view imaging data on mobile devices. Founded in 2016 and headquartered in San Francisco, the company aims to transform healthcare delivery by improving the speed and accessibility of treatment for stroke patients.
Openbay, Inc. is an online marketplace that connects vehicle owners with automotive repair professionals, offering a range of services including air conditioning repairs, battery replacements, brake services, oil changes, and tire replacements. Founded in 2011 and based in Cambridge, Massachusetts, Openbay provides a software-as-a-service (SaaS) platform designed for the automotive care industry. This platform allows consumers to easily find, book, and pay for various automotive maintenance services from car dealerships, national service chains, independent shops, and mobile mechanics. Openbay aims to create a trusted and transparent marketplace for automotive services, helping users compare price quotes and transact conveniently. The company has gained recognition from major media outlets for its innovative approach to the automotive aftermarket and continues to be backed by notable investors.
Owkin is an artificial intelligence company founded in 2016, with headquarters in New York and an additional office in Paris. The company focuses on developing machine learning software for medical research, enabling researchers to test AI models on distributed data. Owkin's offerings include Owkin Lab, which facilitates data connectivity by therapeutic area; Owkin Loop, which provides validated and packaged models; and a comprehensive software stack for full-stack services. The company currently has 30 live models and an additional 40 in development. Owkin aims to empower medical researchers in hospitals, universities, and pharmaceutical companies to better understand variations in drug efficacy among patients, enhance the drug development process, and identify optimal treatments for individual patients, ultimately improving treatment outcomes. The company is supported by various investors and has a scientific board to guide its research initiatives.
Celsius Therapeutics is a biotechnology company focused on developing innovative medicines to treat complex diseases, including autoimmunity and cancer. Founded in 2017 and based in Cambridge, Massachusetts, the company leverages advanced techniques such as single-cell genomic analysis and machine learning to gain insights into the cellular ecosystems of diseases. By systematically applying single-cell sequencing and analyzing extensive datasets with sophisticated algorithms, Celsius Therapeutics aims to discover critical biomarkers and precision therapies that enhance patient care and enable clinicians to identify genes that play a causal role in various conditions.
Insitro, Inc. is a data-driven drug discovery and development company based in South San Francisco, California, founded in 2018. The company utilizes machine learning and high-throughput biology to transform the traditional processes of drug discovery and delivery. By generating extensive functional genomic datasets and aligning them with patient data through innovative machine learning techniques, Insitro builds predictive models that aim to address critical challenges in pharmaceutical research and development. These models facilitate accelerated target selection and the design of effective therapeutics, ultimately enhancing the efficiency of drug development and informing clinical strategies. The focus of Insitro's work includes the treatment of nonalcoholic steatohepatitis (NASH), showcasing its commitment to addressing significant health issues through advanced technology.
Upbound, Inc. is a technology company based in Seattle, Washington, that specializes in providing a multi-cloud platform which allows organizations to manage and optimize services across various public and private cloud environments. Founded in 2017, Upbound offers solutions that enable automation, cost optimization, and policy enforcement, facilitating scalable deployments and application management. Its platform empowers organizations to treat multiple disparate cloud environments as a single cohesive unit, enhancing efficiency and reducing operational costs while ensuring portability and failover capabilities.
SambaNova Systems is a computing startup focused on building machine learning and big data analytics platforms. The company's software defined analytics platform enables optimum performance for any ML training, inference or analytics models.